India needs to treat metabolic dysfunction-associated steatotic liver disease (MASLD) as a public health threat.

Arialys Therapeutics, a clinical-stage biotechnology company pioneering precision medicines for autoimmune neuropsychiatric diseases, today announced that the U.S. Food and Drug Administration (FDA) ...

Summary: Researchers compiled emerging evidence to prove that astrocytes, traditionally dismissed as passive, structural ...

A recent surge in military prescriptions for erectile dysfunction medication is shedding light on broader debates over ...

Muscle wasting in chronic kidney disease (CKD) is a common yet underrecognized complication, tightly intertwined with ...

Cancer is one of the leading causes of death globally, with increasing numbers in incidence and mortality. Cancer incidence is projected to increase by 70% ...

Data on valve durability with transcatheter aortic valve replacement are reassuring at 7 years, with implications for ...

Intracerebral hemorrhage (ICH), typically caused by hypertension or aneurysm rupture, is a devastating subtype of stroke. ICH accounts for approximately 15% ...

Todd Blanche has been vying to be the next attorney general of the United States for quite some time now. During his time as ...

As Democrats scramble to contain a political disaster in Maine, the Republicans on the front lines of the GOP’s fight to hold ...

Post-COVID eye nerve damage leaves millions with corneal nerve loss and pupillary dysfunction that standard exams cannot ...

A study led by researchers at Washington University School of Medicine in St. Louis suggests that an intestinal disorder ...